Equities

Indegene Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Indegene Ltd

Actions
IndustrialsIndustrial Support Services
  • Price (INR)474.70
  • Today's Change5.55 / 1.18%
  • Shares traded1.35m
  • 1 Year change-21.01%
  • Beta--
Data delayed at least 15 minutes, as of Feb 13 2026 10:26 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Indegene Limited is an India-based tech-native, life sciences commercialization company. The Company provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. Its segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Brand Activation, and Others. The Enterprise Commercial Solutions business unit caters to the digital marketing operations of life sciences companies. The Enterprise Medical Solutions consolidates large-scale regulatory and medical operations for life sciences companies. The Brand Activation segment offers promotion of biopharmaceutical products and medical devices to HCPs for life sciences companies across channels. It provides customized marketing campaigns through a comprehensive portfolio of proprietary program offerings. Others mainly consist of consultancy and clinical business.

  • Revenue in INR (TTM)32.63bn
  • Net income in INR4.39bn
  • Incorporated1998
  • Employees4.14k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Quess Corp Ltd150.69bn619.96m30.60bn371.05k49.79--29.480.20314.124.121,009.65--------406,121.90--2.74--5.05100.0095.430.41411.04--5.63--82.359.296.37-65.53---50.44--
Flair Writing Industries Ltd12.25bn1.35bn34.05bn5.44k25.25--18.182.7812.8012.80116.29--------2,251,795.00--------50.39--11.07----32.08----10.33--0.5188------
Seshaasai Technologies Ltd14.05bn2.22bn42.33bn--18.15--16.063.0114.4114.4192.17------------------44.94--15.75----13.49-----6.10--31.33------
SIS Ltd149.20bn-1.88bn46.23bn192.68k------0.3099-13.22-13.221,042.86--------774,333.80--4.56--8.0499.0999.05-1.262.22--3.65--0.007.579.22-93.80-44.5812.87--
Ion Exchange (India) Ltd28.86bn1.82bn47.71bn2.52k25.30--20.131.6515.3415.34243.45--------11,448,350.00--9.37--21.0837.4337.886.318.95--14.68--23.9216.5813.096.0217.8058.4820.11
Cms Info Systems Ltd24.73bn3.22bn53.03bn638.0016.69--10.342.1419.3119.31148.40--------38,766,710.00--13.52--17.5591.0989.2613.0114.82--22.91----7.0615.767.2923.8814.44--
Axiscades Technologies Ltd11.54bn1.02bn60.46bn2.89k61.45--42.205.2423.1423.14261.98--------3,991,407.00--2.30--3.8878.6779.798.942.68--4.82--0.007.929.16128.4120.2942.56--
Eureka Forbes Ltd26.38bn1.61bn100.28bn2.72k62.78--44.453.808.258.25135.51--------9,694,953.00--------59.39--6.11----33.91----11.31--71.90------
Rites Ltd22.63bn4.13bn105.09bn1.76k25.47--20.104.648.588.5847.04--------12,891,740.00--8.43--17.7256.7854.6020.1720.92------85.89-9.58-2.17-15.50-8.983.34-1.15
BLS International Services Ltd28.76bn6.44bn110.86bn737.0017.23--14.333.8515.6315.6369.83--------39,028,760.00--23.09--28.4953.7142.0723.7118.33--25.89--10.8630.8022.7862.3957.5160.9931.95
Indegene Ltd32.63bn4.39bn114.08bn4.14k26.05--20.963.5018.2318.23135.43--------7,879,015.00--15.68--21.01----13.4613.10--32.74--3.539.6434.5920.7948.7737.74--
eClerx Services Limited39.08bn6.69bn169.74bn19.00k26.32--20.304.34139.28139.28813.94--------2,056,855.00--19.13--22.2597.8095.5517.1317.71--19.91--0.938415.0518.555.7920.9628.768.45
Data as of Feb 13 2026. Currency figures normalised to Indegene Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

9.62%Per cent of shares held by top holders
HolderShares% Held
Capital Research & Management Co. (World Investors)as of 31 Dec 20256.80m2.83%
FIL Investment Management (Singapore) Ltd.as of 31 Dec 20254.57m1.90%
Sundaram Asset Management Co. Ltd.as of 31 Jan 20263.78m1.57%
SBI Funds Management Ltd.as of 31 Jan 20263.06m1.27%
ICICI Prudential Asset Management Co. Ltd. (Invt Mgmt)as of 31 Jan 20261.96m0.82%
Helios Capital Asset Management (India) Pvt. Ltd.as of 31 Jan 20261.38m0.57%
Capital Research & Management Co. (Global Investors)as of 31 Dec 2025933.89k0.39%
BlackRock Advisors (UK) Ltd.as of 06 Feb 2026264.06k0.11%
BlackRock Fund Advisorsas of 05 Feb 2026200.49k0.08%
Navi AMC Ltd.as of 31 Dec 2025174.24k0.07%
More ▼
Data from 30 Sep 2025 - 31 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.